N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats

Abstract

The diabetes mellitus (DM) induces several changes, with substantial increase of reactive oxygen species (ROS). The ROS cause damage to systemic and renal microvasculature, which could be one of the mechanisms involved in the development of diabetic nephropathy (DN). The ROS modulate other substances like the nitric oxide (NO), a vasodilator with important role in the renal function. N-acetylcysteine (NAC) is an antioxidant that acts replenishing intracellular cysteine levels, which is essential for glutathione formation. The aim of this study was to evaluate the effect of early or late NAC treatment on oxidative/nitrosative stress in DN progression. All rats were submitted to unilateral nephrectomy and diabetes was induced with streptozotocin. The animals were allocated into six groups: controls that received water (CTL) or NAC (CTL + NAC); diabetic groups that received early or late, water (DM-E; DM-L) or NAC (DM + NAC-E; DM + NAC-L), started on 5th day (early) or 4th week (late) after diabetes induction, during 8 weeks. After NAC treatment, the rats were placed in individual metabolic cages to obtain urine and blood samples for analysis of metabolic profile, renal function, thiobarbituric acid reactive substances (TBARS) and NO. At the end of the protocol, the renal cortex was removed for TBARS, NOS evaluation, antioxidants markers and histology. The DM-E group compared to CTL showed a significant increase in glycemia and proteinuria and impaired renal function; there was a significant increase of TBARS in plasma, urine and renal tissue, and also a significant decrease in plasma NO, which were reverted after early NAC treatment. The eNOS was decreased and iNOS was increased in DM-E vs. CTL, p < 0.05. The early NAC treatment in DM rats reduced proteinuria, creatinine, urea, TBARS and iNOS and, increased creatinine clearance, NO and eNOS, increasing significantly the antioxidant defenses, promoting elevated catalase and glutathione compared to DM-E group, all p < 0.05. The late NAC treatment in diabetic rats vs.DM-E showed reduced proteinuria and TBARS excretion and higher values of creatinine clearance and NO, all statistically significant. Histological analysis of the animals in DM-E or DM-L showed significant tubular changes with degeneration and vacuolization in tubular cells, dilated tubular lumen, intense glycosidic degeneration, and discreet mesangial expansion with interstitial fibrosis area. The DM + NAC-E group showed moderate glycosidic degeneration, however, did not present tubular degeneration or fibrosis. The DM + NAC-L group showed severe glycosidic degeneration, moderate tubular cell degeneration, light and focal dilatation of the tubules, with no fibrosis. Our study showed that NAC protected the diabetic rats against renal injury, probably due to the control of oxidative stress via recovery of the NO bioavailability, showing that early NAC was more effective than late treatment. All these data suggest that NAC may be useful in the adjuvant treatment in a safe way, in the early phase of the disea...

Endothelin-1 induces cellular senescence and fibrosis in cultured myoblasts. A potential mechanism of aging-related sarcopenia

“…As in other aging-related conditions [28,47], higher levels of ROS seem to be involved in ET-1-induced myoblast senescence because the effect disappeared in the presence of NAC. NAC is an antioxidant that acts replenishing intracellular cysteine levels, which are essential for glutathione formation, responsible for detoxify hydrogen peroxide [48]. Furthermore, NAC also prevented FN expression induced by ET-1 treatment.…”

Effects of N‐Acetylcysteine on the reproductive performance, oxidative stress and RNA sequencing of Nubian goats

“…ROS plays a crucial role in the aetiology of abnormal embryo development of mammal species throughout pregnancy (Lan et al, 2019). Extensive research in experimental animals and humans has shown that NAC treatment has protective effects for treating multiple disorders and helps control oxidative stress by increasing NO production (Buhimschi, Buhimschi, & Weiner, 2003;Nogueira et al, 2018). The results in the current work showed that the dietary 0.07% NAC supplementation F I G U R E 1 GO enrichment and KEGG pathway analysis of differentially expressed genes (DEGs) of endometrial tissues between the 0.07% NAC and control groups.…”

N-acetylcysteine resists high-glucose-induced injury of human umbilical vein endothelial cells by inhibiting the leptin/leptin receptor

“…It was originally used as a mucolytic agent in treating respiratory diseases. NAC is also an ROS scavenger, which not only serves as an antioxidant and maintains the redox balance in cells [22] , but also inhibits apoptosis [23] , reduces inflammation response [24] , and is widely used for treating cardiovascular system diseases. Recchioni et al [8] showed that NAC could inhibit HG-induced apoptosis in human large aortic endothelial cells.…”